Among 131,019 women delivering between 240/7-276/7 weeks of gestation during the study period, 199 met the study criteria (Figure 1). The Trial of Labor (TOL) group comprised of 64 women (32.2%), among whom 5 (7.8%) eventually underwent urgent cesarean delivery (CD), with 4 (6.3%) due to non-reassuring fetal heart monitoring (NRFHM) and 1 (1.6%) due to placental abruption. The planned CD group comprised 135 women (67.8%), of whom 73 women (54.1%) had a contraindication for TOL. This included 67 cases (49.6%) with a fetus in a non-vertex presentation and 6 cases (4.4%) with placenta previa.
Maternal and obstetrical characteristics are delineated in Table 1. Within the TOL group, there were higher rates of delivery occurring between 240/7-246/7 weeks of gestation and spontaneous onset of labor. Conversely, the planned CD group had higher rates of preeclampsia (PE)/Hemolysis, Elevated Liver enzymes, and Low Platelets (HELLP) syndrome, as well as non-reassuring fetal heart monitoring (NRFHM) (Table 1).
Table 1. Baseline characteristics of the TOL and planned CD Groups.
|
TOL group (n=64)
|
Planned CD group (n=135)
|
p-value
|
Maternal age, mean (SD)
|
32.8 (6.4)
|
33.5 (6.2)
|
0.485
|
Gestational age, median (IQR)
|
26.0 (24.5-27.0)
|
25.6 (24.5-26.4)
|
0.593
|
Gestational age 240/7-246/7, n (%)
|
16 (25.0%)
|
17 (12.6%)
|
0.028
|
Gestational age 250/7-256/7, n (%)
|
11 (17.2%)
|
38 (28.1%)
|
0.094
|
Gestational age 260/7-266/7, n (%)
|
19 (29.7%)
|
35 (25.9%)
|
0.577
|
Gestational age 270/7-276/7, n (%)
|
18 (28.1%)
|
46 (34.1%)
|
0.401
|
Pre-gestational BMI, median (IQR)
|
21.8 (20.5-25.4)
|
23.0 (19.7-23.9)
|
0.887
|
IVF, n (%)
|
12 (18.8%)
|
33 (24.4%)
|
0.370
|
Nulliparity, n (%)
|
38 (59.4%)
|
64 (47.4%)
|
0.115
|
Previous CD, n (%)
|
6 (9.4%)
|
21 (15.6%)
|
0.234
|
Antepartum steroids, n (%)
|
43 (67.2%)
|
91 (67.9%)
|
0.919
|
Mg, n (%)
|
47 (73.4%)
|
83 (61.9%)
|
0.111
|
Spontaneous onset of labor, n (%)
|
64 (100%)
|
59 (43.7%)
|
<0.001
|
PPROM, n (%)
|
22 (37.3%)
|
27 (27.0%)
|
0.175
|
Uterine rupture, n (%)
|
0
|
6 (4.5%)
|
0.084
|
PE/HELLP, n (%)
|
0
|
20 (14.8%)
|
0.001
|
Placental abruption, n (%)
|
12 (18.8%)
|
28 (20.7%)
|
0.743
|
Chorioamnionitis, n (%)
|
7 (10.9%)
|
20 (14.8%)
|
0.456
|
Pathological blood flow, n (%)
|
0
|
7 (5.2%)
|
0.064
|
NRFHM, n (%)
|
4 (6.3%)
|
29 (21.5%)
|
0.007
|
Meconium, n (%)
|
10 (15.6%)
|
18 (13.4%)
|
0.679
|
Newborn weight, grams (mean ,SD)
|
857 (189)
|
818 (185)
|
0.823
|
Female sex, n (%)
|
25 (39.1%)
|
72 (53.3%)
|
0.060
|
Abbreviations: IVF, in-vitro-fertilization; CD, cesarean delivery; BMI, body-mass-index (kg/m2); Mg, magnesium for neuroprotection; PPROM, preterm premature rupture of membranes; PE, preeclampsia; HELLP, hemolysis elevated liver enzymes, low platelets; NRFHM , non-reassuring fetal heart monitor; SD, standard deviation; IQR, interquartile range
Table 2 presents neonatal outcomes. Among the entire cohort, neonatal death occurred in 48 cases (24.2%), with no significant differences observed between the TOL and planned CD groups (19.0% vs. 26.7%, p=0.244). Similarly, there were no significant differences between the TOL and CD groups concerning the rates of primary (26.6% vs. 31.9%, p=0.448) and overall composite outcomes (85.9% vs. 90.4%, p=0.352). Furthermore, the rates of individual components of secondary outcomes and overall composite outcomes did not vary between the groups (Table 2).
Table 2. Comparison of neonatal outcomes in patients with a TOL and planned CD
|
TOL group (n=64)
|
Planned CD group (n=135)
|
p-value
|
Primary composite outcome, n (%)a
|
17 (26.6%)
|
43 (31.9%)
|
0.448
|
Overall composite outcome, n (%)b
|
55 (85.9%)
|
122 (90.4%)
|
0.352
|
Death, n (%)
|
12 (19.0%)
|
36 (26.7%)
|
0.244
|
5-min Apgar < 7, n (%)
|
21 (32.8%)
|
52 (38.5%)
|
0.435
|
Umbilical arterial PH<7.1, n (%)
|
6 (9.4%)
|
6 (4.4%)
|
0.172
|
Mechanical ventilation, n (%)
|
45 (70.3%)
|
99 (73.3%)
|
0.656
|
BPD, n (%)
|
32 (50.0%)
|
68 (50.4%)
|
0.961
|
IVH, n (%)
|
9 (14.1%)
|
15 (11.1%)
|
0.550
|
NEC, n (%)
|
8 (12.5%)
|
15 (11.1%)
|
0.775
|
PVL, n (%)
|
5 (7.8%)
|
9 (6.7%)
|
0.768
|
Sepsis, n (%)
|
7 (10.9%)
|
15 (11.1%)
|
0.971
|
DIC, n (%)
|
1 (1.6%)
|
5 (3.7%)
|
0.409
|
Abbreviations:; BPD, bronchopulmonary dysplasia; IVH, intraventricular hemorrhage (grade 3/4); NEC, necrotizing enterocolitis (stage 2/3); PVL, periventricular leukomalacia; DIC, disseminated intravascular coagulation; SD, standard deviation; IQR, interquartile range
a Defined as one or more of the following: newborn death prior to discharge, severe neurological injury.
b Defined as one or more of the following: newborn death prior to discharge, severe neurological injury, NEC (stage 2/3), BPD, PVL, mechanical ventilation, neonatal sepsis, arterial ph< 7.1, and DIC
Multivariate analysis, adjusted for gestational age, newborn birthweight, gender, magnesium for neuroprotection, antepartum steroids, spontaneous onset of labor, uterine rupture, non-reassuring fetal heart rate, HELLP syndrome, and pathological blood flow, did not find significant differences between a TOL and CD.
In order to determine the potential impact of TOL on neonatal outcomes, we conducted a sub-analysis, limited to pregnancies with spontaneous onset of labor. The TOL group consisted of 44 deliveries, while the CD group comprised 39 deliveries. Within the TOL group, one delivery (2.3%) required conversion to urgent CD. Notably, among the CD group, 92.3% had a predetermined indication for CD (non-cephalic presentation), while the remaining opted for CD without TOL.
Maternal and obstetrical characteristics were comparable between the groups (Table 3).
Table 3. Subgroup analysis - baseline characteristics of the TOL and planned CD groups with spontaneous onset of labor.
|
TOL (n=44)
|
Planned CD group (n=39)
|
p-value
|
Maternal age, (mean ,SD)
|
33.0 (6.4)
|
34.5 (6.4)
|
0.801
|
Pre- gestational BMI, median (IQR)
|
21.8 (20.5-25.4)
|
23.0 (19.7-23.9)
|
0.593
|
Gestational age, median (IQR)
|
26.0 (24.5-27.0)
|
25.6 (24.5-26.4)
|
0.887
|
Gestational age 240/7-246/7, n (%)
|
14 (31.8%)
|
9 (23.1%)
|
0.375
|
Gestational age 250/7-256/7, n (%)
|
9 (20.5%)
|
10 (25.6%)
|
0.575
|
Gestational age 260/7-266/7, n (%)
|
11 (25.0%)
|
10 (25.6%)
|
0.947
|
Gestational age 270/7-276/7, n (%)
|
10 (22.7%)
|
10 (25.6%)
|
0.757
|
Conception (IVF), n (%)
|
7 (15.9%)
|
6 (15.4%)
|
0.948
|
Nulliparity, n (%)
|
29 (65.9%)
|
18 (46.2%)
|
0.070
|
Previous CD, n (%)
|
5 (11.4%)
|
5 (12.8%)
|
0.839
|
Antepartum steroids, n (%)
|
30 (68.2%)
|
26 (68.4%)
|
0.981
|
Mg, n (%)
|
32 (72.7%)
|
22 (57.9%)
|
0.158
|
PPROM, n (%)
|
15 (37.5%)
|
11 (44.0%)
|
0.603
|
Non-vertex presentation, n (%)
|
0
|
36 (92.3%)
|
<0.001
|
Placenta previa, n (%)
|
0
|
0
|
NA
|
Meconium, n (%)
|
7 (15.9%)
|
3 (7.7%)
|
0.251
|
Newborn weight, grams (mean ,SD)
|
835 (202)
|
847 (165)
|
0.326
|
Female sex, n (%)
|
16 (36.4%)
|
20 (51.3%)
|
0.171
|
Abbreviations: IVF, in-vitro-fertilization; CD, cesarean delivery; BMI, body-mass-index (kg/m2); Mg, magnesium for neuroprotection; PPROM, preterm premature rupture of membranes; SD, standard deviation; IQR, interquartile range
Similarly, rates of primary and overall composite outcomes were similar between the groups (Table 4).
Table 4. Subgroup analysis - neonatal outcomes of TOL and planned CD groups comparing only cases with spontaneous onset of labor.
|
TOL group (n=44)
|
Planned CD group (n=39)
|
p-value
|
Primary composite outcome, n (%)a
|
11 (25.0%)
|
9 (23.1%)
|
0.838
|
Overall composite outcome, n (%)b
|
39 (88.6%)
|
35 (89.7%)
|
0.871
|
Death, n (%)
|
10 (23.3%)
|
7 (17.9%)
|
0.554
|
Apgar < 7 (5 min), n (%)
|
17 (38.6%)
|
12 (37.5%)
|
0.920
|
Umbilical arterial PH <7.1, n (%)
|
5 (11.4%)
|
1 (2.6%)
|
0.122
|
Mechanical ventilation, n (%)
|
31 (70.5%)
|
31 (79.5%)
|
0.345
|
BPD, n (%)
|
24 (54.5%)
|
25 (64.1%)
|
0.377
|
IVH, n (%)
|
6 (13.6%)
|
4 (10.3%)
|
0.637
|
NEC, n (%)
|
5 (11.4%)
|
6 (15.4%)
|
0.590
|
PVL, n (%)
|
4 (9.1%)
|
3 (7.7%)
|
0.819
|
Sepsis, n (%)
|
3 (6.8%)
|
5 (12.8%)
|
0.355
|
DIC, n (%)
|
0
|
0
|
NA
|
Abbreviations BPD, bronchopulmonary dysplasia; IVH, intraventricular hemorrhage (grade 3/4); NEC, necrotizing enterocolitis (stage 2/3); PVL, periventricular leukomalacia; DIC, disseminated intravascular coagulation; SD, standard deviation; IQR, interquartile range
a Defined as one or more of the following: newborn death prior to discharge, severe neurological injury.
b Defined as one or more of the following: newborn death prior to discharge, severe neurological injury, NEC (stage 2/3), BPD, PVL, mechanical ventilation, neonatal sepsis, arterial ph< 7.1, and DIC
Given the significant disparities in preterm birth rates within the gestational age range of 240/7-246/7 weeks, we conducted a supplementary sub-analysis excluding this period and focusing on pregnancies within the range of 250/7-276/7weeks. Within this gestational age range, the TOL group experienced higher rates of magnesium treatment for neuroprotection and spontaneous onset of labor. Conversely, the CD group exhibited increased prevalance of NRFHM and PE/HELLP syndrome (Table 5).
Table 5. Subgroup analysis - baseline characteristics of the TOL and planned CD groups between 250/7-276/7 weeks of gestation.
|
TOL group (n=48)
|
Planned CD group (n=118)
|
p-value
|
Maternal age, mean (SD)
|
32.6 (6.9)
|
33.2 (6.0)
|
0.097
|
Gestational age, median (IQR)
|
26.5 (26.0-27.2)
|
26.4 (25.6-27.2)
|
0.597
|
Gestational age 250/7-256/7, n (%)
|
11 (22.9%)
|
37 (31.4%)
|
0.277
|
Gestational age 260/7-266/7, n (%)
|
19 (39.6%)
|
35 (29.7%)
|
0.216
|
Gestational age 270/7-276/7, n (%)
|
18 (37.5%)
|
46 (39.0%)
|
0.859
|
Pre-gestational BMI, median (IQR)
|
21.7 (20.7-23.8)
|
22.5 (20.3-25.0)
|
0.531
|
IVF, n (%)
|
9 (18.8%)
|
29 (24.6%)
|
0.418
|
Nulliparity, n (%)
|
28 (58.3%)
|
56 (47.5%)
|
0.204
|
Previous CD, n (%)
|
4 (8.3%)
|
19 (16.1%)
|
0.189
|
Antepartum steroids, n (%)
|
35 (72.9%)
|
78 (66.7%)
|
0.433
|
Mg, n (%)
|
37 (77.1%)
|
70 (59.8%)
|
0.035
|
Spontaneous onset of labor, n (%)
|
48 (100%)
|
45 (38.1%)
|
<0.001
|
PPROM, n (%)
|
14 (31.1%)
|
25 (27.8%)
|
0.687
|
Uterine rupture, n (%)
|
0
|
4 (3.4%)
|
0.193
|
PE/HELLP, n (%)
|
0
|
20 (16.9%)
|
0.002
|
Placental abruption, n (%)
|
11 (22.9%)
|
24 (20.3%)
|
0.712
|
Chorioamnionitis, n (%)
|
6 (12.5%)
|
19 (16.1%)
|
0.556
|
Pathological blood flow, n (%)
|
0
|
7 (5.9%)
|
0.085
|
NRFHM, n (%)
|
4 (8.3%)
|
28 (23.7%)
|
0.023
|
Meconium, n (%)
|
7 (14.6%)
|
17 (14.5%)
|
0.993
|
Newborn weight, grams (mean ,SD)
|
922 (164)
|
834 (190)
|
0.098
|
Female sex, n (%)
|
21 (43.8%)
|
63 (53.4%)
|
0.260
|
Abbreviations: IVF, in-vitro-fertilization; CD, cesarean delivery; BMI, body-mass-index (kg/m2); Mg, magnesium for neuroprotection; PPROM, preterm premature rupture of membranes; PE, preeclampsia; HELLP, hemolysis elevated liver enzymes, low platelets; NRFHM , non-reassuring fetal heart monitor; SD, standard deviation; IQR, interquartile range
Table 6 delineates neonatal outcomes in patients with a TOL and planned CD between 250/7-276/7 weeks of gestation. Notably, no significant difference were found between the groups regarding primary and overall composite outcomes. However, the TOL group displayed a trend towards lower rates of neonatal mortality compared to the CD group, although statistical significance was not achieved (10.4% vs. 22.9%, p=0.065).
Table 6. Subgroup analysis - comparison of neonatal outcomes in patients with a TOL and planned CD between 250/7-276/7 weeks of gestation.
|
TOL group (n=48)
|
Planned CD group (n=118)
|
p-value
|
Primary composite outcome, n (%)a
|
9 (18.8%)
|
33 (28.0%)
|
0.216
|
Overall composite outcome, n (%)b
|
40 (83.3%)
|
105 (89.0%)
|
0.321
|
Death, n (%)
|
5 (10.4%)
|
27 (22.9%)
|
0.065
|
5-min Apgar < 7, n (%)
|
16 (33.3%)
|
41 (34.7%)
|
0.862
|
Umbilical arterial PH <7.1, n (%)
|
3 6.3%)
|
5 (4.2%)
|
0.583
|
Mechanical ventilation, n (%)
|
33 (68.8%)
|
86 (72.9%)
|
0.592
|
BPD, n (%)
|
27 (56.3%)
|
61 (51.7%)
|
0.594
|
IVH, n (%)
|
6 (12.5%)
|
11 (9.3%)
|
0.540
|
NEC, n (%)
|
7 (14.6%)
|
12 (10.2%)
|
0.418
|
PVL, n (%)
|
4 (8.3%)
|
8 (6.3%)
|
0.726
|
Sepsis, n (%)
|
5 (10.4%)
|
12 (10.2%)
|
0.962
|
DIC, n (%)
|
1 (2.1%)
|
5 (4.2%)
|
0.500
|
Abbreviations:; BPD, bronchopulmonary dysplasia; IVH, intraventricular hemorrhage (grade 3/4); NEC, necrotizing enterocolitis (stage 2/3); PVL, periventricular leukomalacia; DIC, disseminated intravascular coagulation; SD, standard deviation; IQR, interquartile range
a Defined as one or more of the following: newborn death prior to discharge, severe neurological injury.
b Defined as one or more of the following: newborn death prior to discharge, severe neurological injury, NEC (stage 2/3), BPD, PVL, mechanical ventilation, neonatal sepsis, arterial ph< 7.1, and DIC